Aclaris Therapeutics logo
Aclaris Therapeutics ACRS
€ 3.49 3.29%

Geschäftsbericht 2025
hinzugefügt 26.02.2026

report update icon

Aclaris Therapeutics DSO 2011-2026 | ACRS

DSO Jährlich Aclaris Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 2.91 4.57 6.79 37.7 41.6 60.8 176 104 - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
176 2.91 54.3

DSO Vierteljährlich Aclaris Therapeutics

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- 11.4 17.8 - 7.01 11.5 12.8 - 3.82 27.3 21.1 - 1.43 18.9 39.4 - 48.1 43.9 40.8 - 48.6 34.4 47.9 - 65.3 72.5 45.8 14 221 121 218 43.9 64.2 - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
221 1.43 50.1

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
37.5 $ 22.57 0.04 % $ 3.74 B usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
222 - - $ 86.2 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
48.3 - -24.86 % $ 820 K usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
62.9 $ 1.41 -1.4 % $ 363 M usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
Aravive Aravive
ARAV
16.8 - -13.39 % $ 1.45 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
150 $ 2.56 -3.76 % $ 16.1 M usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
16.2 K $ 3.85 -1.39 % $ 9.26 B australiaAustralia
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
70.9 $ 20.87 2.3 % $ 976 M usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
103 $ 4.17 -0.24 % $ 446 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
106 $ 24.57 -0.16 % $ 3.13 B usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
182 - - $ 3.45 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
45.6 - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
2.26 K - - $ 1.41 B usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
28.1 $ 2.93 -4.87 % $ 6.38 B israelIsrael
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
6.83 - - $ 169 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
13.6 - - $ 867 M germanyGermany
Celldex Therapeutics Celldex Therapeutics
CLDX
321 $ 33.62 3.73 % $ 2.23 B usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
147 - - $ 401 M usaUSA
Celsion Corporation Celsion Corporation
CLSN
15.6 - -6.63 % $ 13.9 M usaUSA